Status:
COMPLETED
Phase I Study to Assess Absorption, Metabolism & Excretion of a Single Oral Dose [14C]AZD0530 in Healthy Male Volunteers
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
MALE
50+ years
Phase:
PHASE1
Brief Summary
The aim of this study is to show how the body absorbs, metabolises and excretes the drug \[14C\]AZD0530. As for all clinical trials, safety and tolerability of the drug will be evaluated.
Eligibility Criteria
Inclusion
- Regular Daily Bowel movements
- Veins suitable for cannulation or repeated venepuncture
Exclusion
- Presence of any clinically significant illness
- Abnormal vital signs
- History or presence of gastrointestinal, hepatic or renal disease or any other condition known to interfere with absorption, distribution, metabolism or excretion of drugs
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00853983
Start Date
March 1 2009
End Date
April 1 2009
Last Update
May 21 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Alderley Park, Cheshire, United Kingdom